Portland, OR, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The sleep aids market size accounted for $49,543 million in 2016 and is estimated to reach $79,851 million by 2023, registering a CAGR of 7.0% from 2017 to 2023. North America is the highest contributor in the sleep aids market; however, Asia-Pacific has witnessed the highest growth rate in 2016.
Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-for-customization/1533?reqfor=covid
Sleep aids in the form of drugs and medical devices are used for the diagnosis and treatment of sleep disorders, such as sleep apnea and sleepwalking. These are expected to improve the quality of sleep for patients with sleep disorders. Sleep disorders could adversely affect human health and cause chronic diseases, such as diabetes and cardiovascular diseases.
Change in lifestyle, stressful working conditions, other issues that interfere with sleep habits, rise in disposable income among the customers, and growth in awareness about the adverse effects of sleep disorder on human health are expected to boost the growth of the sleep aids market. The risk of sleep disorder increases with age and obesity thus, the rise in the geriatric and obese population could increase the prevalence of sleep disorder, which is expected to fuel the market growth. The rise in demand for sleep aids has also lead to an increase in the advancement of technology, which will further open new avenues for market growth. However, the adverse effects of sleep drugs on human health and patent expiration are expected to hamper the market growth.
The mattress & pillows segment was the highest revenue contributor in 2016 and is anticipated to continue this trend during the forecast period. The availability of a variety of products, awareness about the health benefits of quality sleep, and advancement in manufacturing techniques are some of the driving factors for the growth of this segment. Insomnia dominates the sleep aids market and is expected to remain the highest contributor toward the market growth, owing to the presence of a large population base suffering from insomnia.
For Purchase Enquiry at https://www.alliedmarketresearch.com/purchase-enquiry/1533
In 2015, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of sleep disorders, the presence of high disposable income, and the high adoption rate of technologically advanced products. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to a rise in disposable income, an increase in government initiatives to modernize healthcare infrastructure and rise in healthcare expenditure.
The key companies profiled in the report include
- Koninklijke Philips N.V.
- Merck & Co.
- Sanofi
- eVilbiss Healthcare LLC.
- Pfizer Inc.
- SleepMed Inc.
- Cadwell Laboratories Inc.
- Compumedics Limited
- Natus Medical Incorporated, and
- GlaxoSmithKline plc
Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at:
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Similar Reports:
Vascular Guidewires Market - Global Opportunity Analysis and Industry Forecast, 2020–2027
Smart Pulse Oximeters Market - Global Opportunity Analysis and Industry Forecast, 2019-2026
Medical Electrodes Market - Global Opportunity Analysis and Industry Forecast, 2019-2026
Intraocular Lens Market - Global Opportunity Analysis and Industry Forecast, 2019–2026
Nurse Call Systems Market - Global Opportunity Analysis and Industry Forecast, 2019-2026
Medical Device Coatings Market - Global Opportunity Analysis and Industry Forecast, 2019–2026
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.